Gerresheimer AG (ETR:GXI) received a €85.00 ($95.51) price target from research analysts at Berenberg Bank in a research note issued to investors on Wednesday, May 24th. The brokerage presently has a “buy” rating on the stock.
Gerresheimer AG (GXI) traded up 0.99% on Wednesday, reaching €72.59. The company’s stock had a trading volume of 56 shares. The stock has a market cap of €2.28 billion and a P/E ratio of 19.33. The stock has a 50-day moving average of €74.45 and a 200-day moving average of €72.90. Gerresheimer AG has a one year low of €62.00 and a one year high of €79.47.
COPYRIGHT VIOLATION WARNING: “Gerresheimer AG (GXI) Given a €85.00 Price Target by Berenberg Bank Analysts” was posted by Markets Daily and is owned by of Markets Daily. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.themarketsdaily.com/2017/06/16/gerresheimer-ag-gxi-given-a-85-00-price-target-at-berenberg-bank-updated-updated.html.
About Gerresheimer AG
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings.
Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.